alexa Guidelines Proposal For Nanomaterials Hemocompatibility
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Nanotek & Expo
December 01-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Julie Laloy
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439.S1.017
Nanosciences and nanotechnologies are in constant evolution. Development of new therapeutic and diagnostic agents using nanotechnologies for reach their pharmaceutical target require the knowledge of biocompatibility of nanoparticles with the blood compounds. The aim of this study is the evaluation of the biocompatibility of manufactured nanoparticles (NPs) (carbon based, silver, silicon dioxide, copper oxide and silicon carbide nanoparticles) on erythrocytes integrity, on platelets aggregation and on coagulation cascade. Hemostasis is the ensemble of physiological phenomena which prevent and lead to stop bleeding; it maintains the vascular integrity. A dysfunction of the hemostasis can lead to slow down or even to completely stop the circulation of the blood. It is therefore primordial to know what NPs can have an effect on coagulation. Various techniques assessing activation and aggregation of the platelets or the impact of NPs on coagulation cascade were investigated. An approach in transmission and in scanning electronic microscopy was also accomplished. The Impact-R? with scanning electronic microscopy support and the calibration thrombin generation tests were the reference method to investigate the potential impact of NPs on platelet function and the procoagulant activity of NPs, respectively. Based on the results obtained, we suggest guidelines for testing NP hemocompatibility which responds to a request of scientific community due to lack of recommendations for the evaluation of nanomaterial hemocompatibility.
Julie Laloy obtained her PhD in 2012 at the University of Namur on in vivo and ex vivo evaluation of the potential toxicity of manufactured nanomaterials. Her research is focused on the safety assessment of nanomaterials. Mrs Laloy is an actor in the standardization of procedure for nanomaterials and on the reglementation of them in Europe. In fact, she participated in different European projects as NanoValid, QNano and NANoREG. She is european coordinator of the NanoGeCo project. She has published more than 10 papers in reputed journals and serving as an editorial board member of repute.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version